The Effects of r-metHuIFN-Gamma on the Lungs of Patients With AIDS
NCT00002433 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12
Last updated 2005-06-24
Summary
To determine safety and tolerance of administering aerosolized recombinant interferon gamma (IFN-gamma) for 4 weeks in patients with AIDS. To examine activation of alveolar macrophages by aerosolized IFN-gamma administration. To determine if subcutaneous (SC) injection of IFN-gamma can activate alveolar macrophages in AIDS patients.
Conditions
- HIV Infections
Interventions
- DRUG
-
Interferon gamma-1b
Sponsors & Collaborators
- lead INDUSTRY
Study Design
- Purpose
- TREATMENT
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
Countries
- United States
Study Locations
More Related Trials
-
A Multicenter, Double-Blind, Phase III, Adjuvant-Controlled Study of the Effect of 10 Units of HIV-1 Immunogen (Remune) Compared to Incomplete Freund's Adjuvant (IFA) Alone Every 12 Weeks on AIDS-Free Survival in Subjects With HIV Infection and CD4 T-Lymphocytes Between 300 and 549 Cells/microL Rega
NCT00002359 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Tolerability of Pegylated Interferon (PEG-IFN) Alfa-2a in HIV Infected People
NCT00078442 ·Status: COMPLETED ·Phase: PHASE2
-
Phase I Study to Evaluate the Safety and Immunogenicity of HIV-1 Immunogen in Children With HIV-1 Infection
NCT00001445 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase I Study of Recombinant CD4(rCD4) in Patients With AIDS and AIDS-Related Complex
NCT00002005 ·Status: COMPLETED ·Phase: NA
-
N-803 Combined With the Broadly Neutralizing Antibodies Plus or Minus haNK Cells for HIV
NCT04144335 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Phase II Study of AGS-004 as an Immunotherapeutic in Antiretroviral Therapy (ART)-Treated Subjects Infected With HIV
NCT00672191 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate Safety, Tolerance and Efficacy of ASC22 Combined With ART in Subjects With HIV
NCT05330143 ·Status: COMPLETED ·Phase: PHASE2
-
A Pilot Study of Allogeneic Lymphocyte Transfer in HIV Infection
NCT00000852 ·Status: COMPLETED ·Phase: NA
-
A Multicenter, Prospective, Randomized, Double-Blind, Placebo-Controlled Trial of Three Preparations of Low-Dose Oral Alpha Interferon in HIV-Infected Patients With CD4+ Counts >= 50 and <= 350 Cells/mm3
NCT00000844 ·Status: COMPLETED ·Phase: NA
-
Effects of Immunization With HIV-1 Immunogen Plus Anti-HIV Treatment Interruption on the Levels of HIV
NCT00021762 ·Status: WITHDRAWN ·Phase: PHASE2
-
Reducing HIV Persistence in Lymph Nodes by Interleukin-15 (IL-15) Receptor Super-agonist (N-803) in Acute HIV Infection
NCT04505501 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Safety and Effectiveness of Treating HIV-Positive Patients With an HIV Vaccine (Remune)
NCT00005001 ·Status: COMPLETED ·Phase: PHASE2
-
Safety, Tolerability, and Efficacy of IL-15 Superagonist (N-803) With and Without Combination Broadly Neutralizing Antibodies to Induce HIV-1 Control During Analytic Treatment Interruption
NCT04340596 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
A Pilot Study to Examine the Feasibility and Effect of Tumor Necrosis Factor (TNF) Inhibition on HIV Disease
NCT00205231 ·Status: COMPLETED ·Phase: NA
-
Safety and Effectiveness of an Adjuvant in Improving Immune Response to Hepatitis B Virus Vaccine in HIV Infected Individuals
NCT00272493 ·Status: COMPLETED ·Phase: PHASE2
-
Double-Blind, Randomized, Dose Ranging Study of Alferon LDO (Low Dose Oral Interferon Alfa-n3 (Human Leukocyte Derived)) in HIV+ Subjects
NCT00002018 ·Status: COMPLETED ·Phase: NA
-
Safety and Immune Response to Adjuvanted A(H1N1)v Influenza Vaccine in HIV-1 Infected and Immunosuppressed Adult Patients
NCT01017172 ·Status: UNKNOWN ·Phase: PHASE4
-
Evaluation of the Safety and Tolerance of Immunotherapy With Autologous, Ex-Vivo Expanded, HIV-Specific Cytotoxic T-Cells in HIV-Infected Patients With CD4+ Counts Between 100-400/mm3
NCT00000756 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Trials on the Effect of Immunity 1 (Fuzheng 1) on Immune Reconstitution of HIV Patients
NCT00974285 ·Status: UNKNOWN ·Phase: NA
-
An Open-Label Phase I/II Study of Recombinant Granulocyte Colony Stimulating Factor (r-metHuG-CSF) and Recombinant Erythropoietin (rHuEPO) Given Subcutaneously Along With Zidovudine (AZT) to Patients With the Acquired Immune Deficiency Syndrome (AIDS) or Severe AIDS-Related Complex (ARC)
NCT00002255 ·Status: COMPLETED ·Phase: PHASE1
-
A Pilot Study of Immunization With HIV-1 Antigen Pulsed Allogenic Dendritic Cells in HIV-Infected Asymptomatic Patients With CD4+ T Cells > 350 Cells/mm3
NCT00001064 ·Status: TERMINATED ·Phase: NA
-
Study of Anti-HIV Therapy Intensification
NCT00034086 ·Status: COMPLETED ·Phase: NA
-
A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 (rCD4) in Patients With AIDS and AIDS-Related Complex
NCT00002004 ·Status: COMPLETED ·Phase: PHASE1
-
Effectiveness of Treating HIV-Positive Patients With an HIV Vaccine (Remune)
NCT00005002 ·Status: UNKNOWN ·Phase: PHASE3
-
Leukapheresis to Obtain Plasma or Lymphocytes for Studies of HIV-infected Patients, Including Long-term Non-progressors
NCT00029445 ·Status: RECRUITING